iANTHUS CAPITAL HOLDINGS (ITHUF) Equity Average (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Equity Average came in at -$109.9 million in Q1 2026, down 75.67% year-on-year from -$451.9 million in Q1 2025, and down 14.14% quarter-over-quarter from -$96.3 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Equity Average (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Equity Average across 7 years of filings, most recently posting -$109.9 million for Q1 2026.
- Equity Average for Q1 2026 came in at -$109.9 million, down 75.67% year-over-year; the trailing twelve-month figure through Mar 2026 was -$109.9 million (down 75.67% YoY), and the FY2025 annual result was -$84.3 million, down 32.52% from the prior year.
- Equity Average came in at -$109.9 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from -$96.3 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $62.3 million in Q3 2022 to a low of -$109.9 million in Q1 2026.
- The 5-year median for Equity Average is -$62.6 million (2025), against an average of -$44.0 million.
- Across the five-year window, Equity Average soared 607.59% in 2022 and tumbled 2991.05% in 2024, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Equity Average stood at $32.3 million in 2022, then tumbled by 262.94% to -$52.7 million in 2023, then plunged by 51.17% to -$79.6 million in 2024, then dropped by 21.01% to -$96.3 million in 2025, then declined by 14.14% to -$109.9 million in 2026.
- The last three Equity Average figures came in at -$109.9 million (Q1 2026), -$96.3 million (Q4 2025), and -$83.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | -109.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -109.94 Mn |
| Dec 31, 2025 | -96.32 Mn |
| Sep 30, 2025 | -83.76 Mn |
| Jun 30, 2025 | -68.77 Mn |
| Mar 31, 2025 | -62.58 Mn |
| Dec 31, 2024 | -79.59 Mn |
| Sep 30, 2024 | -88.04 Mn |
| Jun 30, 2024 | -77.91 Mn |
| Mar 31, 2024 | -67.52 Mn |
| Dec 31, 2023 | -52.65 Mn |
| Sep 30, 2023 | -34.27 Mn |
| Jun 30, 2023 | -15.61 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 32.31 Mn |
| Sep 30, 2022 | 62.31 Mn |
| Jun 30, 2022 | 19.35 Mn |
| Mar 31, 2022 | -27.96 Mn |
| Dec 31, 2021 | -10.97 Mn |
| Sep 30, 2021 | 8.81 Mn |
| Jun 30, 2021 | 22.71 Mn |